H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharma (BHVN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NYSE: BHVN) | Delayed: 10.78 -0.65 (5.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.43 | 52 Week High | $ | |||
| Open | $11.31 | 52 Week Low | $ | |||
| Day High | $11.40 | P/E | N/A | |||
| Day Low | $10.70 | EPS | $ | |||
| Volume | 2,423,734 | |||||
